XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.48

+0.5%

9:49 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: opalapril who wrote (8029)	12/12/1998 3:01:00 PM
From: Arthur Radley	Read Replies (2) of 17367

It does state...."the proposed change should provide a more favorable corporate structure for expansion of XOMA's current business and FUTURE strategic alliance and acquisition opportunities and, consequently, may enhance the Company's relationship with pharmaceutical industry participants". The word SHOULD is very broad as it relates to reality. It also bothers me that they have taken a circuitous route through Arizona to break the covenents of the domicile in Delaware. Maybe I'm reading more into this than what it appears, but I don't find the approach being very American. I also find it strange that many major European drug companies that are domiciled in much heavier taxing nations than the U.S.....(.Novartis, Rhone and others), haven't taken this Bermuda route for their domicile. What I find truly amazing about this whole issue, is that I'm seriously thinking about adding to my long term position in XOMA stock. Go figure!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next